Ronjon Nag

Ronjon Nag is the Founder and President of R42 Group, a family office and venture group specializing in investments related to AI, biotechnology, and wireless communication technologies since September 2019. Concurrently, Nag serves as an Adjunct Professor in Genetics at Stanford University, teaching courses on artificial intelligence and longevity science, while also holding the position of Stanford Distinguished Careers Institute Interdisciplinary Fellow and Visiting Fellow at the Stanford Center for the Study of Language and Information. Additionally, Nag is a Director for MIT Alumni Angels of Northern California and an Advisor to the UC Berkeley Skydeck Accelerator. In various entrepreneurial ventures, Nag is the Co-Founder and CEO of AGEMICA, focused on developing a vaccine for aging, and holds leadership roles at Superbio.ai, Ecrio, GTCardio, and Bounce Imaging. Educational qualifications include a PhD in Engineering from the University of Cambridge, an S.M. from MIT Sloan School of Management, and additional fellowships and degrees from Stanford University.